Investor Kit

Company Profile

Founded in 1995, Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.

Acorda has an industry leading pipeline of novel neurological therapies addressing a range of disorders, including Parkinson’s disease, post-stroke walking difficulty, migraine, and multiple sclerosis. Acorda markets three FDA-approved therapies, including AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg.

Stock Chart


Date Filing Description Download
09/27/16 4 Statement of Changes in Beneficial Ownership
08/15/16 8-K Current report filing
08/11/16 4 Statement of Changes in Beneficial Ownership
08/04/16 10-Q Quarterly Report

Stock Quote

ACOR (Common Stock) $ 22.06 -0.93 (-4.05%) Volume: 1,321,409 MORE September 27, 2016

Email Alerts

Un-subscribe from email alerts
Email Address *
Mailing Lists *

Enter the code shown above.